MW Why investors are so eager for the SpaceX IPO countdown
By Philip van Doorn
Also in Weekend Reads: The global energy market's long road back after the Iran conflict ends, differences between new GLP-1 pills, and a simple 50/50 investment portfolio
SpaceX, whose Crew Dragon Endeavour spacecraft is shown here undocking from the International Space Station Jan. 14, has reportedly filed a confidential registration with the Securities and Exchange Commission for an initial public offering of $75 billion in stock, which could value the entire company at $1.75 trillion.
The successful launch of the Artemis II mission on Wednesday and its translunar injection burn Thursday evening have been inspiring, with the smooth operations capping a two-decade effort.
The good vibes may help Elon Musk with his plan to take SpaceX public, possibly in June. On Wednesday, Bloomberg reported that SpaceX had filed a draft registration for an initial public offering with the Securities and Exchange Commission. The company is expected to issue $75 billion in stock as it seeks a valuation of $1.75 billion. Musk is the CEO of SpaceX and of Tesla $(TSLA)$.
William Gavin explained why SpaceX started its IPO process with a confidential filing, provided an example to illustrate institutional investors' enthusiasm and discussed how the company's financials relate to the size of the offering and potential valuation.
Related coverage from William Gavin:
-- Nasdaq paves the way for SpaceX and OpenAI to quickly join a premier index after IPOs
-- This space stock is hot - and both Amazon and SpaceX may want to buy it
-- Amazon's satellite business gets another win as it seeks to challenge Musk's Starlink
-- Moon launches are having a moment. But can you make money off the lunar frenzy?
How long will it take for the global oil market to recover?
When the conflict between the U.S., Israel and Iran ends, a quick euphoric reaction in financial markets may be expected. Here is a possible timeline for the complicated process of restoring the full international flow of crude oil and liquefied natural gas, as explained by Myra P. Saefong in the Commodities Corner column.
More on commodities: Gold's bull run faces hurdles but finish line is not necessarily in view, according to UBS strategist
A moving target: Investors are growing concerned about Trump's new 'two- to three-week' timeline on Iran
Another disruption: 'Liberation day' one year later: What Trump's tariffs are costing America
Companies
This Nike store in Shanghai opened in January 2025.
On Tuesday, Nike $(NKE)$ CEO Elliott Hill said during an earnings conference call that he expected actions under his two-year turnaround plan for the company to be completed by the end of this year. Bill Peters explained why Nike's stock fell 16% on Wednesday.
More on Nike:
-- Nike's price decline sets up a buying opportunity for long-term investors
-- Frustrated with Nike's failing turnaround? Give this stock a try instead, analyst says.
More coverage from the MarketWatch Companies team:
-- Airline stocks drop, but worries over rising fuel prices haven't hurt travel demand yet
-- Boeing's stock surges again after 7-year missile deal with the Trump administration
-- Starbucks made two big moves to help its turnaround - but they didn't help the coffee chain's stock
-- Blue Owl stokes more private-credit worries, as it paid out less than a quarter of requests
Stock picks: Why Delta, Starbucks and these other stocks were just added to a market-beating 'fresh money' list
Life is getting easier for people who want medication to help them lose weight
People who have been receiving GLP-1 injections to treat diabetes or to lose weight now have another oral medication to consider, with FDA approval this week for Eli Lilly's $(LLY)$ Foundayo.
Jaimy Lee - MarketWatch's healthcare editor - explained the differences between Foundayo and the Wegovy pill made by Novo Nordisk (DK:NOVO.B).
More healthcare coverage:
-- With Zepbound approved for sleep apnea, Lilly spends up to $7.8 billion for a company with a narcolepsy drug
-- HSAs are being touted as a way to make healthcare more affordable. But it's more complicated than that.
Can you trust an adviser to keep your money safe?
There are many types of financial adviser. Some are fiduciaries, bound by pledges to look after your best interests, while others - even some good ones - are not fiduciaries. In the Fix My Portfolio column, Beth Pinsker looked into the mechanics of how brokerage and advisory accounts are set up and offered tips on what to ask advisers, what permissions to grant them and how to maintain control over your money.
More on advisers: I'm 75 and retired. Should I put my life savings into CDs or hire a financial adviser to help?
More from Beth Pinsker: How to make Roth IRAs work for you at any age
Food for thought - a simple and successful stock-market portfolio
Steve Goldstein explained how a 50/50 allocation between two exchange-traded funds achieved double-digit returns in six of the past seven years.
Apple turns 50
The Apple II computer made its debut in 1977.
Apple $(AAPL)$ is now 50 years old. Christine Ji looked into the company's efforts to integrate advanced artificial-intelligence features into the iPhone.
Read on: A venture capital investor's written opinion of Apple 50 years ago
More from the MarketWatch Technology team:
-- Verizon is coming off its best quarter in 15 years. Can it sustain that momentum?
-- Intel's stock has been climbing - and this could be its next big catalyst
-- Microsoft is sitting on a 'treasure chest' that could help lift the stock 20%
-- Here's why Palo Alto Networks and other cybersecurity stocks are now standout gainers
The Moneyist helps with estate planning
Quentin Fottrell is the Moneyist.
This week Quentin Fottrell - the Moneyist - answered questions from a reader who is living in a house with his mother, who has offered to sell him the house at a 40% discount to its market value. The reader, who takes care of his mother, wants to be fair to his siblings. How should the house deal and his mother's estate plan be structured?
Another estate plan: My husband is giving me 75% of his trust - and allocating 25% to his sister. Is that fair?
Advice from a MarketWatch reader: 'I was shoveling sidewalks at 8 years old': I'm a 73-year-old boomer dad with two kids. Here's what I teach them about finance.
Where to stash your cash
You might be in the habit of keeping a certain amount of cash on hand for emergencies, but how much interest are you earning on that money? A typical savings account at a bank might be paying you one-tenth of 1%, at a time when you can easily earn 3.5% or more in a high-yield savings account.
Genna Contino explained how to set up a bucket strategy for your cash and allocate it to earn as much as possible, while making sure you have enough on hand for emergencies.
More from Genna Contino:
-- Employers are using your personal data to figure out the lowest salary you'll accept
-- Don't short yourself: I'm a personal finance reporter who never budgeted. Then my boyfriend got laid off.
Dismal: What's an 'E-shaped' economy - and where do you fit in it?
What to stream and how much to pay for it
Mike Murphy has done his usual thorough job of surveying new movies and shows on Netflix $(NFLX)$, Amazon Prime (AMZN), Disney+ $(DIS)$, Paramount + $(PSKY)$, HBO Max $(WBD)$ (on which Alien: Romulus began streaming on April 3) and three other services, along with advice on whether or not to pay for each service in April. Since you are not locked into contracts with streamers, Murphy's month-to-month rotation strategy might save you a lot of money.
Here is what's worth streaming during April and which services to play, pause or stop.
Want more from MarketWatch? Sign up for this and other newsletters to get the latest news and advice on personal finance and investing.
-Philip van Doorn
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 03, 2026 12:53 ET (16:53 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments